《腺性膀胱炎临床诊断和治疗中国专家共识》解读-泌尿外科杂志(电子版)

摘要：腺性膀胱炎（cystitis glandular，CG）属于膀胱黏膜化生性病变，自 1899年由 Stoerk首次报道，至今已有 100多年的历史，其是否应被视为癌前病变一直存有争议。CG 临床表现复杂多样，且缺乏疾病特异性症状。目前国际上无论欧洲还是北美，尚没有关于 CG的诊治指南和共识。中华医学会泌尿外科学分会腺性膀胱炎诊治专家共识编写组，于2020年8月在《中华泌尿外科杂志》发表的《腺性膀胱炎的临床诊断和治疗的专家共识》对 CG的发病机制、临床分型、诊断标准统一了认识，对CG的治疗策略做了规范化指导。本文就此版专家共识中一些与临床诊疗密切相关的内容进行解读。

暂无相关信息！

[1] BELL TE, WENDEL RG. Cystitis glandularis: benign or malignant? [J]. J Urol, 1968,100(4):462-465

[2] 中华医学会泌尿外科学分会,腺性膀胱炎诊治专家共识编写组. 腺性膀胱炎临床诊断和治疗中国专家共识[J].中华泌尿外科杂志,2020,41(8):566-568

[3] WILLIAMSON SR, LOPEZ- BELTRANA, MONTIRONIR, et al, Glandular lesions of the urinary bladder: Clinical significance and differential diagnosis [J]. Histopathology, 2011,58(6):811-834.[4] KAYA C, AKPINAR IN, AKER F, et al. Large Cystitis glandularis: a very rare cause of severe obstructive urinary symptoms in an adult [J]. Int Urol Nephrol, 2007,39 (2):441-444

[5] WIENER DP, KOSS LG, SABLAY B. The prevalence and significance of Brunn's nests, cystitiscystica and squamous metaplasia in normal bladders [J]. J Urol, 1979,122 (3):317-321

[6] LI C, HU J, LIU P, et al. A comprehensive evaluation of differentially expressed mRNAs and lncRNAs in cystitis glandularis with gene ontology, KEGG pathway, and ceRNA network analysis [J]. Transl Androl Urol, 2020,9(2): 232-242

[7] QU Y, CHEN X, CUI Y, et al. Changes of bladder mucosal inflammatory factors and prognosis in cystitis glandularis [J]. Int J Clin Exp Pathol, 2018,11(7):3591-3597

[8] LI Z, GE G, FENG R, et al. Cyclooxygenase-2 and Bcell lymphoma-2 expression in cystitis glandularis and primary vesicle adenocarcinoma [J]. BMC Urol, 2014,14:2

[9] EPSTEIN JI, AMIN MB, REUTER VE. Bladder Biopsy Interpretation [M ]. Philadelphia: Lippincott Williams & Wilkins, 2004:150-176

[10] VOLMAR KE, CHAN TY, DE MARZO AM, et al. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma [J]. Am J Surg Pathol, 2003,27(9):1243-1252

[11] MORTON MJ, ZHANG S, LOPEZ-BELTRAN A, et al. Telomereshortening and chromosomal abnormaliies in intestinal metaplasia of the urinary bladder [J]. Clin Cancer Res, 2007,13(20):6232-6236

[12] AGRAWAL A, KUMAR D, JHA AA, et al. Incidence of adenocarcinoma bladder in patients with cystitis cystica et glandularis: A retrospective study [J]. Indian J Urol, 2020,36(4):297-302

[13] GOMEZ DSV, BURGOS RF, GARCIA GR. Cistitis glandular. Tratamiento esteroideo endovesical [Glandular cystitis. Endovesical steroid treatment] [J]. Arch Esp Urol, 2000,53(5):461-464

[14] MAEDA M, HIRABAYASHI T, INUZUKA Y, et al. Case of cystitis glandularis causing bilateral hydronephrosis [J]. Nihon Hinyokika Gakkai Zasshi, 2013,104(5):671-673

[15] BENCHAKROUN A, ZANNOUD M, NOUINI Y, et al. Pseudo- tumoral colic metaplasia of the urinary bladder [J]. Prog Urol, 2002,12(2):325-328

[16] MITRE AI, SILVEIRA CA, LEITE KR, et al. Glandular cystitis: A rare benign condition presenting as a pseudotumor of the bladder clinics [J]. Open J Urol, 2007,62(1): 93-94

[17] LIU XG, CHEN ZQ, YE ZQ. Etiological study on cystitis glandularis caused by bacterial infection [J]. J Huazhong Univ Sci Technolog Med Sci, 2007,27(6):678-680

[18] TOUFFAHI M, FREDJ N, LEFI M, et al. To analyse diagnosis, management and prognosis of florid cystitis glandularis (pseudoneoplastic entity) [J]. Prog Urol, 2007,17(5): 968-972

[19] MASUMORI N, TSUKAMOTO T. Pelvic lipomatosis associated with proliferative cystitis: case report and review of the japanese literature [J]. Int J Urol, 1999,6(1):44-49

[20] ZHANG W, YAO YS, LIN ME, et al. Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study [J]. Int Urogynecol J, 2015,26(12):1835-1841

[21] WANG HJ, PUI MH, GUO Y, et al. Preliminary study of diffusion- weighted MRI in the preoperative diagnosis of cystitis glandularis [J]. Clin Radiol, 2016,71(9):937

[22] XIN Z, ZHAO C, HUANG T, et al. Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome [J]. BMC Urol, 2016,16(1):24

[23] SUNG MT, LOPEZ- BELTRAN A, EBLE JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder [J]. Mod Pathol, 2006,19(11): 1395-1401

[24] JANKOVIC VL, KATIC V, HATTORI T, et al. Differences in the expression of mucins in various forms of cystitis glandularis [J]. Pathol Res Pract, 2007,203(9):653- 658

[25] FENG Z, SHI H, LIANG B, et al. Bioinformatics and experimental findings reveal the therapeutic actions and targets of pachymic acid against cystitis glandularis [J]. Biofactors, 2021,47(4):665-673

[26] TAKIZAWA N, MATSUZAKI T, YAMAMOTO T, et al. Novel strategy for cystitis glandularis: oral treatment with cyclooxygenase-2 inhibitor [J]. Int J Urol, 2016,23(8):706- 708

[27] HU J, LI C, GUO X, et al. Development and validation of a predictive nomogram for the risk of recurrence in patients with cystitis glandularis [J]. Ann Transl Med, 2020,8 (6):352.

张保. 《腺性膀胱炎临床诊断和治疗中国专家共识》解读[J]. 泌尿外科杂志（电子版）,2021,13(4):28-31. DOI:10.3969/j.issn.1674-7410.2021.04.008.

暂无相关信息！

摘要：腺性膀胱炎（cystitis glandular，CG）属于膀胱黏膜化生性病变，自 1899年由 Stoerk首次报道，至今已有 100多年的历史，其是否应被视为癌前病变一直存有争议。CG 临床表现复杂多样，且缺乏疾病特异性症状。目前国际上无论欧洲还是北美，尚没有关于 CG的诊治指南和共识。中华医学会泌尿外科学分会腺性膀胱炎诊治专家共识编写组，于2020年8月在《中华泌尿外科杂志》发表的《腺性膀胱炎的临床诊断和治疗的专家共识》对 CG的发病机制、临床分型、诊断标准统一了认识，对CG的治疗策略做了规范化指导。本文就此版专家共识中一些与临床诊疗密切相关的内容进行解读。

1 CG 的发病机制

2 CG 的分型

3 CG 的临床表现和诊断

4 CG 的治疗

暂无相关信息！